Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP203481.RAR94RRtNChBFmWX9nJLSg2XHy6TVQU4ztwID4VQBnVvI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP203481.RAR94RRtNChBFmWX9nJLSg2XHy6TVQU4ztwID4VQBnVvI130_assertion type Assertion NP203481.RAR94RRtNChBFmWX9nJLSg2XHy6TVQU4ztwID4VQBnVvI130_head.
- NP203481.RAR94RRtNChBFmWX9nJLSg2XHy6TVQU4ztwID4VQBnVvI130_assertion description "[Gastrointestinal stromal tumor secondary KIT mutations can be associated with KIT hyperactivation and imatinib resistance, in which AKT PI3-kinase is a crucial survival pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP203481.RAR94RRtNChBFmWX9nJLSg2XHy6TVQU4ztwID4VQBnVvI130_provenance.
- NP203481.RAR94RRtNChBFmWX9nJLSg2XHy6TVQU4ztwID4VQBnVvI130_assertion evidence source_evidence_literature NP203481.RAR94RRtNChBFmWX9nJLSg2XHy6TVQU4ztwID4VQBnVvI130_provenance.
- NP203481.RAR94RRtNChBFmWX9nJLSg2XHy6TVQU4ztwID4VQBnVvI130_assertion SIO_000772 17546049 NP203481.RAR94RRtNChBFmWX9nJLSg2XHy6TVQU4ztwID4VQBnVvI130_provenance.
- NP203481.RAR94RRtNChBFmWX9nJLSg2XHy6TVQU4ztwID4VQBnVvI130_assertion wasDerivedFrom lhgdn-20090331 NP203481.RAR94RRtNChBFmWX9nJLSg2XHy6TVQU4ztwID4VQBnVvI130_provenance.
- NP203481.RAR94RRtNChBFmWX9nJLSg2XHy6TVQU4ztwID4VQBnVvI130_assertion wasGeneratedBy ECO_0000203 NP203481.RAR94RRtNChBFmWX9nJLSg2XHy6TVQU4ztwID4VQBnVvI130_provenance.